Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 16, Pages 3940
Publisher
MDPI AG
Online
2019-08-14
DOI
10.3390/ijms20163940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of carcinoid syndrome: a systematic review and meta-analysis
- (2019) Johannes Hofland et al. ENDOCRINE-RELATED CANCER
- Therapeutic Options for Neuroendocrine Tumors
- (2019) Reto M. Kaderli et al. JAMA Oncology
- Diversity and Function of Somatostatin-Expressing Interneurons in the Cerebral Cortex
- (2019) Therese Riedemann INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
- (2018) Tobias Hofving et al. ENDOCRINE-RELATED CANCER
- Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence
- (2018) Lingaku Lee et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain
- (2018) Priyank A. Shenoy et al. Frontiers in Pharmacology
- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
- (2018) André Lacroix et al. Lancet Diabetes & Endocrinology
- International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
- (2018) Thomas Günther et al. PHARMACOLOGICAL REVIEWS
- Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
- (2018) Aura D. Herrera-Martínez et al. DRUGS
- The safety of lanreotide for neuroendocrine tumor
- (2018) Amandeep Godara et al. Expert Opinion On Drug Safety
- mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors
- (2018) C. S. Lewis et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells
- (2018) Federico Gatto et al. Pituitary
- Expression and selective activation of somatostatin receptor subtypes induces cell cycle arrest in cancer cells
- (2018) Yi Zou et al. Oncology Letters
- Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
- (2017) Sue Ping Thang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas
- (2017) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
- (2017) Piero Ferolla et al. LANCET ONCOLOGY
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
- (2017) Kjell Oberg et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
- (2017) Marianne Pavel et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification
- (2017) Aurel Perren et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy
- (2017) Rocio Garcia-Carbonero et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues
- (2017) Rodney J. Hicks et al. NEUROENDOCRINOLOGY
- The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review
- (2017) Michael Michael et al. ONCOLOGIST
- The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
- (2017) Jonathan R. Strosberg et al. PANCREAS
- Somatostatin receptor ligands in the treatment of acromegaly
- (2017) Monica R. Gadelha et al. Pituitary
- Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
- (2017) James Yao et al. OncoTargets and Therapy
- Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
- (2017) Amira Mohamed et al. Oncotarget
- Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis
- (2017) Elettra Merola et al. Oncotarget
- Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach
- (2017) Rudolf A. Werner et al. Theranostics
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
- (2017) Bryan Oronsky et al. NEOPLASIA
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Disinhibition in learning and memory circuits: New vistas for somatostatin interneurons and long-term synaptic plasticity
- (2017) Julien Artinian et al. BRAIN RESEARCH BULLETIN
- Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study
- (2016) S. Faivre et al. ANNALS OF ONCOLOGY
- Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study
- (2016) Philippe Ruszniewski et al. DIGESTIVE AND LIVER DISEASE
- Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
- (2016) Kjell Öberg et al. ENDOCRINE-RELATED CANCER
- Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly
- (2016) Federico Gatto et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas
- (2016) Roberto Würth et al. MOLECULAR NEUROBIOLOGY
- Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells
- (2016) Roxanne C.S. van Adrichem et al. NEUROENDOCRINOLOGY
- Dysfunction of Somatostatin-Positive Interneurons Associated with Memory Deficits in an Alzheimer’s Disease Model
- (2016) Lena C. Schmid et al. NEURON
- Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors
- (2016) Zhi Rong Qian et al. PANCREAS
- Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas
- (2016) Anat Ben-Shlomo et al. Pituitary
- The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
- (2016) Manuel D. Gahete et al. Oncotarget
- Everolimus in the management of metastatic neuroendocrine tumours
- (2016) David L. Chan et al. Therapeutic Advances in Gastroenterology
- Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives
- (2015) Thomas Cuny et al. ANNALES D ENDOCRINOLOGIE
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1
- (2015) T. Vandamme et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells
- (2015) Sajad A. War et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
- (2015) Annamaria Colao et al. Pituitary
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- (2015) Edward Wolin et al. Drug Design Development and Therapy
- Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
- (2015) Daniel Kaemmerer et al. Oncotarget
- Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
- (2015) Miguel Sampedro-Núñez et al. Oncotarget
- Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma
- (2014) J Yamamoto et al. BRITISH JOURNAL OF CANCER
- Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures
- (2014) A. Mohamed et al. ENDOCRINE-RELATED CANCER
- Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors
- (2014) M Cives et al. ENDOCRINE-RELATED CANCER
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- RETRACTED ARTICLE: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients
- (2014) Jun Yao et al. MEDICAL ONCOLOGY
- Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor
- (2014) Andreas Lehmann et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
- (2014) Federica Barbieri et al. International Journal of Endocrinology
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors
- (2013) Edward M. Wolin CANCER LETTERS
- Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
- (2013) M. Ruscica et al. CURRENT MOLECULAR MEDICINE
- Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies
- (2013) Federica Barbieri et al. DRUG DISCOVERY TODAY
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
- (2013) R. van der Pas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: Effect of mono- and bi-specific somatostatin analogs on cell growth
- (2013) M. Ruscica et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Illuminating somatostatin analog action at neuroendocrine tumor receptors
- (2013) Jean Claude Reubi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
- (2012) Gou Mizutani et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers: A Single-Center, Open-Label, Ascending-Dose Study
- (2012) Stephan Petersenn et al. CLINICAL THERAPEUTICS
- Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
- (2012) Larry K Kvols et al. ENDOCRINE-RELATED CANCER
- Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study
- (2012) H. Dietrich et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- PDZ Domain-containing 1 (PDZK1) Protein Regulates Phospholipase C-β3 (PLC-β3)-specific Activation of Somatostatin by Forming a Ternary Complex with PLC-β3 and Somatostatin Receptors
- (2012) Jung Kuk Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Somatostatin and Cognitive Function in Neurodegenerative Disorders
- (2012) Gabor Tuboly et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Angiogenesis in Neuroendocrine Tumors: Therapeutic Applications
- (2012) Jean-Yves Scoazec NEUROENDOCRINOLOGY
- The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
- (2012) Su-Chen Li et al. PLoS One
- Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors
- (2012) R. H. Oakley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)
- (2011) M. S. Khan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology
- (2011) José Córdoba-Chacón et al. Annals of the New York Academy of Sciences
- Receptor specific crosstalk and modulation of signaling upon heterodimerization between β1-adrenergic receptor and somatostatin receptor-5
- (2011) Rishi K. Somvanshi et al. CELLULAR SIGNALLING
- Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins
- (2011) Federico Gatto et al. CLINICAL ENDOCRINOLOGY
- The role of somatostatin and dopamine D2 receptors in endocrine tumors
- (2011) Federico Gatto et al. ENDOCRINE-RELATED CANCER
- Neuroendocrine tumors: recent progress in diagnosis and treatment
- (2011) Kjell Oberg ENDOCRINE-RELATED CANCER
- Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors
- (2011) Jens Hasskarl et al. Future Oncology
- Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
- (2011) John A. Jane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Structural Determinants of Agonist-Selective Signaling at the sst2ASomatostatin Receptor
- (2011) Falko Nagel et al. MOLECULAR ENDOCRINOLOGY
- Ligand-Dependent Mechanisms of sst2A Receptor Trafficking: Role of Site-Specific Phosphorylation and Receptor Activation in the Actions of Biased Somatostatin Agonists
- (2011) Yachu J. Kao et al. MOLECULAR ENDOCRINOLOGY
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
- (2010) V. Cerovac et al. CANCER RESEARCH
- Chemokines and chemokine receptors: New actors in neuroendocrine regulations
- (2010) William Rostène et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Elucidation of the Self-Assembly Pathway of Lanreotide Octapeptide into β-Sheet Nanotubes: Role of Two Stable Intermediates
- (2010) Emilie Pouget et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Pasireotide and Octreotide Stimulate Distinct Patterns of sst2ASomatostatin Receptor Phosphorylation
- (2010) Florian Pöll et al. MOLECULAR ENDOCRINOLOGY
- The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement
- (2010) Günter Klöppel et al. VIRCHOWS ARCHIV
- Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice
- (2009) Federica Barbieri et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
- (2009) Anat Ben-Shlomo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- The clinical–molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
- (2009) Diego Ferone et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Regulation of prostate cancer cell proliferation by somatostatin receptor activation
- (2009) Massimiliano Ruscica et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Agonist-Biased Signaling at the sst2A Receptor: The Multi-Somatostatin Analogs KE108 and SOM230 Activate and Antagonize Distinct Signaling Pathways
- (2009) Renzo Cescato et al. MOLECULAR ENDOCRINOLOGY
- Site Specificity of Agonist and Second Messenger-Activated Kinases for Somatostatin Receptor Subtype 2A (Sst2A) Phosphorylation
- (2009) Q. Liu et al. MOLECULAR PHARMACOLOGY
- Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors
- (2008) A. Moreno et al. ENDOCRINE-RELATED CANCER
- Somatostatin Receptors 1, 2, and 5 Cooperate in the Somatostatin Inhibition of C6 Glioma Cell Proliferationin Vitrovia a Phosphotyrosine Phosphatase-η-Dependent Inhibition of Extracellularly Regulated Kinase-1/2
- (2008) Federica Barbieri et al. ENDOCRINOLOGY
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
- (2008) C de Bruin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Cortistatin—Functions in the central nervous system
- (2008) Luis de Lecea MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization
- (2008) Michael Grant et al. MOLECULAR ENDOCRINOLOGY
- Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
- (2007) Tullio Florio Frontiers in Bioscience-Landmark
- Somatostatin agonists for treatment of acromegaly
- (2007) Anat Ben-Shlomo et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Selective agonism in somatostatin receptor signaling and regulation
- (2007) Agnes Schonbrunn MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Somatostatin/somatostatin receptor signalling: Phosphotyrosine phosphatases
- (2007) Tullio Florio MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line
- (2007) Simona Grozinsky-Glasberg et al. NEUROENDOCRINOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started